Protara Therapeutics (TARA)
(Delayed Data from NSDQ)
$3.19 USD
-0.02 (-0.62%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.18 -0.01 (-0.31%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Protara Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
TARA 3.19 -0.02(-0.62%)
Will TARA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TARA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TARA
Protara Therapeutics (TARA) Moves to Buy: Rationale Behind the Upgrade
TARA Stock Soars on Superior Efficacy of Bladder Cancer Cell Therapy
TARA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TARA
Is TARA ready to move higher? 20 Day Moving Average Support shows up after sliding 0.62%
Analysts Predict Up to 840% Jump for These 2 ‘Strong Buy’ Penny Stocks
Crossed Above 20 Day Moving Average appears for TARA after 5.94% move
Stochastic Reached Oversold appears for TARA after 1.3% move
Citizens JMP healthcare analysts hold an analyst/industry conference call